Survival of patients with prior anti-angiogenic therapy

Neuro Oncol. 2018 May 18;20(6):860-861. doi: 10.1093/neuonc/noy039.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Anilides / therapeutic use*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / mortality*
  • Brain Neoplasms / pathology
  • Glioblastoma / drug therapy
  • Glioblastoma / mortality*
  • Glioblastoma / pathology
  • Humans
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / mortality*
  • Neovascularization, Pathologic / pathology
  • Prognosis
  • Pyridines / therapeutic use*
  • Survival Rate

Substances

  • Angiogenesis Inhibitors
  • Anilides
  • Pyridines
  • cabozantinib